OpenAI’s CEO of AGI Deployment, Fidji Simo, Is Stepping Down

OpenAI’s chief executive of AGI deployment, Fidji Simo, is leaving her full-time role at the company and transitioning to become a part-time adviser. The move…

OpenAI’s Chief Futurist Is Leaving the Company

OpenAI’s chief futurist, Joshua Achiam, notified colleagues on Tuesday that he is leaving the company later this month after nearly nine years, WIRED has learned.…

Can OpenAI’s ‘Master of Disaster’ Fix AI’s Reputation Crisis?

Three months ago, OpenAI cofounder Greg Brockman told me his concerns about a mounting public relations crisis facing artificial intelligence companies: Despite the popularity of…

Greg Brockman Officially Takes Control of OpenAI’s Products in Latest Shakeup

OpenAI told staff on Friday that it would reorganize the company as part of an ongoing effort to unify its product offerings, WIRED has learned.…

‘I Actually Thought He Was Going to Hit Me,’ OpenAI’s Greg Brockman Says of Elon Musk

In August 2017, Greg Brockman and Ilya Sutskever gathered at Elon Musk’s self-described “haunted mansion,” a 47-acre, $23 million estate in Hillsborough, south of San…

Elon Musk Seemingly Admits xAI Has Used OpenAI’s Models to Train Its Own

While testifying on Thursday in federal court, Elon Musk seemed to indicate that his AI lab may have used OpenAI’s models to train xAI’s own.…

The Battle for OpenAI’s Soul

Elon Musk’s lawsuit against Sam Altman will head to trial this month in an Oakland, California, federal courtroom, where nine jurors will settle a years-long…

Inside OpenAI’s Race to Catch Up to Claude Code

Sam Altman sits with his legs pretzeled in an office chair, staring deeply into the ceiling. To be fair, the new OpenAI headquarters—a temple of…

OpenAI’s President Gave Millions to Trump. He Says It’s for Humanity

OpenAI’s president and cofounder Greg Brockman doesn’t consider himself political, which is surprising, because he was one of President Trump’s biggest individual donors of 2025.…

From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development |

Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques, like high-throughput screening, offer an…